# Systemic Pharmacokinetics of BOL-303224-A

> **NCT00407589** · PHASE1 · COMPLETED · sponsor: **Bausch & Lomb Incorporated** · enrollment: 24 (actual)

## Conditions studied

- Conjunctivitis, Bacterial

## Interventions

- **DRUG:** BOL-303224-A

## Key facts

- **NCT ID:** NCT00407589
- **Lead sponsor:** Bausch & Lomb Incorporated
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2011-12-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00407589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00407589, "Systemic Pharmacokinetics of BOL-303224-A". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00407589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*